IL130921A - Tetrahydroisoindole and hexahydroisoindole derivatives - Google Patents

Tetrahydroisoindole and hexahydroisoindole derivatives

Info

Publication number
IL130921A
IL130921A IL13092195A IL13092195A IL130921A IL 130921 A IL130921 A IL 130921A IL 13092195 A IL13092195 A IL 13092195A IL 13092195 A IL13092195 A IL 13092195A IL 130921 A IL130921 A IL 130921A
Authority
IL
Israel
Prior art keywords
isoindole
methyl
tetrahydro
represents hydrogen
ylamine
Prior art date
Application number
IL13092195A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL130921A publication Critical patent/IL130921A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
IL13092195A 1994-10-04 1995-10-02 Tetrahydroisoindole and hexahydroisoindole derivatives IL130921A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4435479A DE4435479A1 (de) 1994-10-04 1994-10-04 Chinolon- und Naphthyridoncarbonsäure-Derivate
IL11549295A IL115492A (en) 1994-10-04 1995-10-02 Quinolone and naphthyridonecarboxylic acid derivatives their preparation and antibacterial compositions containing them

Publications (1)

Publication Number Publication Date
IL130921A true IL130921A (en) 2001-10-31

Family

ID=6529941

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13092195A IL130921A (en) 1994-10-04 1995-10-02 Tetrahydroisoindole and hexahydroisoindole derivatives
IL11549295A IL115492A (en) 1994-10-04 1995-10-02 Quinolone and naphthyridonecarboxylic acid derivatives their preparation and antibacterial compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11549295A IL115492A (en) 1994-10-04 1995-10-02 Quinolone and naphthyridonecarboxylic acid derivatives their preparation and antibacterial compositions containing them

Country Status (40)

Country Link
US (1) US5679689A (cs)
EP (1) EP0705828B1 (cs)
JP (1) JP3794737B2 (cs)
KR (1) KR100371883B1 (cs)
CN (1) CN1063747C (cs)
AT (1) ATE187171T1 (cs)
AU (1) AU697608B2 (cs)
BG (1) BG62965B1 (cs)
CA (1) CA2159547A1 (cs)
CO (1) CO4480031A1 (cs)
CU (1) CU22751A3 (cs)
CZ (1) CZ291616B6 (cs)
DE (2) DE4435479A1 (cs)
DK (1) DK0705828T3 (cs)
DZ (1) DZ1933A1 (cs)
EE (1) EE03443B1 (cs)
ES (1) ES2140599T3 (cs)
FI (1) FI954680A7 (cs)
GR (1) GR3032659T3 (cs)
HR (1) HRP950469B1 (cs)
HU (1) HUT73429A (cs)
IL (2) IL130921A (cs)
MA (1) MA23682A1 (cs)
MY (1) MY113196A (cs)
NO (1) NO307514B1 (cs)
NZ (1) NZ280129A (cs)
PE (1) PE29698A1 (cs)
PL (1) PL182812B1 (cs)
PT (1) PT705828E (cs)
RO (1) RO115261B1 (cs)
RU (1) RU2145604C1 (cs)
SG (1) SG38880A1 (cs)
SI (1) SI0705828T1 (cs)
SK (1) SK280877B6 (cs)
SV (1) SV1995000063A (cs)
TN (1) TNSN95099A1 (cs)
TW (1) TW364908B (cs)
UA (1) UA42797C2 (cs)
YU (1) YU63595A (cs)
ZA (1) ZA958296B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US8163769B2 (en) * 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
CA2518443A1 (en) * 2003-03-12 2004-09-30 Abbott Laboratories Naphthyridine derivatives as antibacterial agents
AU2007339692B2 (en) 2007-01-05 2012-01-19 Daiichi Sankyo Company, Limited Fused substituted aminopyrrolidine derivative
PH12022551260A1 (en) * 2019-11-28 2024-06-03 Bayer Ag Substituted aminoquinolones as dgkalpha inhibitors for immune activation
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
CA2030217A1 (en) * 1989-11-21 1991-05-22 Jun Imose Pyridone-carboxylic acid derivatives useful as veterinary medicines
JPH03181478A (ja) * 1989-12-08 1991-08-07 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
JPH04253973A (ja) 1990-04-20 1992-09-09 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
WO1992012146A1 (en) * 1990-12-27 1992-07-23 Banyu Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
EP0812838B1 (en) * 1994-02-04 2002-05-02 Dainippon Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate

Also Published As

Publication number Publication date
ATE187171T1 (de) 1999-12-15
CZ256895A3 (en) 1996-04-17
UA42797C2 (uk) 2001-11-15
IL115492A (en) 1999-12-22
CN1126211A (zh) 1996-07-10
AU697608B2 (en) 1998-10-15
SK280877B6 (sk) 2000-08-14
DE4435479A1 (de) 1996-04-11
JP3794737B2 (ja) 2006-07-12
BG62965B1 (bg) 2000-12-29
SI0705828T1 (en) 2000-02-29
MY113196A (en) 2001-12-31
ES2140599T3 (es) 2000-03-01
SG38880A1 (en) 1997-04-17
FI954680A0 (fi) 1995-10-02
DZ1933A1 (fr) 2002-02-17
TNSN95099A1 (fr) 1996-02-06
AU3291995A (en) 1996-04-18
PL182812B1 (pl) 2002-03-29
NO307514B1 (no) 2000-04-17
EP0705828A1 (de) 1996-04-10
DE59507324D1 (de) 2000-01-05
US5679689A (en) 1997-10-21
HRP950469B1 (en) 2000-12-31
FI954680L (fi) 1996-04-05
SV1995000063A (es) 1996-07-24
CZ291616B6 (cs) 2003-04-16
HRP950469A2 (en) 1997-08-31
RO115261B1 (ro) 1999-12-30
CU22751A3 (es) 2002-02-28
YU63595A (sh) 1998-08-14
PT705828E (pt) 2000-04-28
FI954680A7 (fi) 1996-04-05
NO953931L (no) 1996-04-09
RU2145604C1 (ru) 2000-02-20
KR100371883B1 (ko) 2003-03-29
KR960014118A (ko) 1996-05-22
ZA958296B (en) 1996-05-07
GR3032659T3 (en) 2000-06-30
IL115492A0 (en) 1996-01-19
TW364908B (en) 1999-07-21
SK123895A3 (en) 1996-06-05
CA2159547A1 (en) 1996-04-05
EE03443B1 (et) 2001-06-15
BG100041A (bg) 1996-05-31
HU9502888D0 (en) 1995-11-28
PL310747A1 (en) 1996-04-15
EE9500069A (et) 1996-04-15
CN1063747C (zh) 2001-03-28
HUT73429A (en) 1996-07-29
DK0705828T3 (da) 2000-05-15
JPH08225567A (ja) 1996-09-03
NO953931D0 (no) 1995-10-03
CO4480031A1 (es) 1997-07-09
NZ280129A (en) 1996-06-25
MA23682A1 (fr) 1996-07-01
EP0705828B1 (de) 1999-12-01
PE29698A1 (es) 1998-08-27

Similar Documents

Publication Publication Date Title
US8969561B2 (en) Apixaban preparation process
DE69723846T2 (de) Verfahren zur Herstellung von Sildenafil
JP6061158B2 (ja) 6−(7−((1−アミノシクロプロピル)メトキシ)−6−メトキシキノリン−4−イルオキシ)−n−メチル−1−ナフトアミド、またはそれの薬学的に許容される塩の合成中間体およびその使用
KR940006764B1 (ko) (z)-1-페닐-1-디에틸아미노카르보닐-2-아미노메틸싸이클로프로판 염산염의 제조방법
CA2988594C (en) Methods of making protein deacetylase inhibitors
WO2016207364A1 (en) Process for the preparation of a xanthine-based compound
IL130921A (en) Tetrahydroisoindole and hexahydroisoindole derivatives
JP2002544207A (ja) 2,2−ジメチル−1,3−ジオキサン中間体の塩及びその製法
US6548665B2 (en) Asymmetric synthesis of a key intermediate for making benazepril and analogues thereof
US5110946A (en) Preparation of 4-chloro-3-sulphamoyl-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)-benzamide from 2,3-dihydro-2-methyl-1h-indole and hydroxylamine-o-sulphonic acid
US4697024A (en) Medroxalol intermediates
KR20090055638A (ko) 2,5-비스-(2,2,2-트리플루오로에톡시)-n-(2-피페리딜메틸)벤즈아미드 및 그 염들의 제조방법
JP2001523219A (ja) カルボキサミド側鎖を有するステロイドの調製方法
EP1513868B1 (en) Process for the production of lisinopril
AU647562B2 (en) Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
KR100900177B1 (ko) 트리테르펜 유도체의 제조 방법
US4029647A (en) Synthesis of biotin
US4701541A (en) Medroxalol intermediates
US6426417B1 (en) Processes and intermediates useful to make antifolates
JPH069553A (ja) 1−[|2s|−メチル−3−メルカプトプロピオニル−ピロリジン−|2s|−カルボン酸の製法
JPH05331139A (ja) 2−アザビシクロ[2.2.1ヘプト−5−エン−3−オンの製造法
EP1698611A1 (en) Process for producing phenylacetic acid derivative
JPH0912546A (ja) アザビシクロ環化合物および製造方法
HU194198B (en) Process for preparing n-methyl-s-methyl-n'-square brackets open 2-(2-dimehtylaminomethyl-thiazol-4-yl-methyl-thio)-ethyl square brackets closed-isothiourea
JPH1087586A (ja) 鏡像異性的に純粋なシクロペンタン−β−アミノ酸の調製のための新規な効率的で高度にエナンチオ選択的な方法